129 Risk Mitigation of Gastrointestinal Bleeding in Patients Co-Prescribed Antiplatelets with Oral Anticoagulants: VISN 8 Anticoagulation Stewardship Proton Pump Inhibitor Initiative

Introduction: Concomitant antiplatelet (APT) therapy in patients receiving oral anticoagulation (OAC) is a common and modifiable risk factor for major bleeding. Within Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 8 an ongoing anticoagulation stewardship initiative has focused on ensuring combination therapy is utilized only in appropriate settings. While combination therapy in VISN 8 has decreased by about 35% with this initiative nearly 1 out of 6 patients continue combined therapy.

Authors

Institutions

Publication Details

Journal
Research and Practice in Thrombosis and Haemostasis
Published
2025-05-01
DOI
https://doi.org/10.1016/j.rpth.2025.102752
Primary Topic
Antiplatelet Therapy and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

129 Risk Mitigation of Gastrointestinal Bleeding in Patients Co-Prescribed Antiplatelets with Oral Anticoagulants: VISN 8 Anticoagulation Stewardship Proton Pump Inhibitor Initiative

Jaclyn Stoppi, Jennifer Crowley, Joseph J. Fierro, David Parra et al.
Research and Practice in Thrombosis and Haemostasis
Antiplatelet Therapy and Cardiovascular Diseases
article

129 Risk Mitigation of Gastrointestinal Bleeding in Patients Co-Prescribed Antiplatelets with Oral Anticoagulants: VISN 8 Anticoagulation Stewardship Proton Pump Inhibitor Initiative

Jaclyn Stoppi, Jennifer Crowley, Joseph J. Fierro, David Parra, Jeffery L. Kibert, Emily Wilson, Robert D. Stewart, Laura K. Vinieratos, Natalie R. Ciccone, Litzalee Camacho-Vega, Joseph Capriola, Alida Marrero-Hernandez, Maria J. Irias
article en

Abstract

Introduction: Concomitant antiplatelet (APT) therapy in patients receiving oral anticoagulation (OAC) is a common and modifiable risk factor for major bleeding. Within Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 8 an ongoing anticoagulation stewardship initiative has focused on ensuring combination therapy is utilized only in appropriate settings. While combination therapy in VISN 8 has decreased by about 35% with this initiative nearly 1 out of 6 patients continue combined therapy.

Research and Practice in Thrombosis and HaemostasisVol. 9
University of Minnesota (US), Orlando Health (US), Bay Pines VA Healthcare System (US), North Florida/South Georgia Veterans Health System (US), West Palm Beach VA Medical Center (US), Orlando VA Medical Center (US), VA Caribbean Healthcare System (PR), Miami VA Healthcare System (US), Tampa Bay Research Institute (US)
Openalex Percentile: Top 77%
Antiplatelet Therapy and Cardiovascular Diseases
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

129 Risk Mitigation of Gastrointestinal Bleeding in Patients Co-Prescribed Antiplatelets with Oral Anticoagulants: VISN 8 Anticoagulation Stewardship Proton Pump Inhibitor Initiative — Jaclyn Stoppi, Jennifer Crowley, et al. · Research and Practice in Thrombosis and Haemostasis (2025) | TGRS Research Map | TGRS